Human Merkel cell polyomavirus: virological background and clinical implications

Area of Science:

• Virology
• Oncology
• Dermatology

Background:

• Merkel cell polyomavirus (MCPyV), identified in 2008, is linked to Merkel cell carcinoma (MCC), an aggressive neuroendocrine skin cancer.
• MCC incidence is rising due to aging populations, increased sun exposure, and a growing number of immunocompromised individuals.
• MCPyV is the first identified human oncogenic polyomavirus, with widespread, lifelong infections common in adults.

Purpose of the Study:

• To establish MCPyV as the etiological agent of MCC.
• To explore MCPyV's role in human health and disease beyond MCC.
• To understand the transmission, host cells, and latency of MCPyV.

Main Methods:

• Seroprevalence studies to assess widespread exposure.
• Investigation of persistent MCPyV infections in healthy skin.
• Further research into MCPyV's association with various diseases.

Main Results:

• MCPyV is confirmed as the etiological agent of MCC.
• Widespread MCPyV exposure occurs early in life, with most adults having anti-MCPyV antibodies.
• Evidence suggests MCPyV persists throughout life in healthy skin.

Conclusions:

• MCPyV is a significant human oncogenic virus, causally linked to MCC.
• Further research is needed to elucidate MCPyV's transmission, cellular tropism, and latency.
• Understanding MCPyV's role may lead to improved MCC diagnosis and treatment strategies.